Loading insider details...
Beta
Latest Form 4 (Jan 21, 2026): Grant/Award of 60,000 GALT shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jan 21, 2026 | GALECTIN THERAPEUTICS INC (GALT) | Grant/Award | 60,000 | n/a |
| Jan 27, 2025 | GALECTIN THERAPEUTICS INC (GALT) | Grant/Award | 60,000 | n/a |
| Dec 26, 2024 | GALECTIN THERAPEUTICS INC (GALT) | Purchase | 10,000 | $8.2K |
| Aug 26, 2024 | GALECTIN THERAPEUTICS INC (GALT) | Purchase | 1,000 | $2.3K |
| Apr 30, 2024 | GALECTIN THERAPEUTICS INC (GALT) | Purchase | 1,000 | $3.5K |
| Feb 7, 2024 | GALECTIN THERAPEUTICS INC (GALT) | Grant/Award | 50,000 | n/a |
| Jan 30, 2023 | GALECTIN THERAPEUTICS INC (GALT) | Grant/Award | 40,000 | n/a |
| Jul 29, 2022 | GALECTIN THERAPEUTICS INC (GALT) | Purchase | 5,000 | $12.5K |
| Apr 4, 2022 | GALECTIN THERAPEUTICS INC (GALT) | Purchase | 5,000 | $8.0K |
| Jan 25, 2022 | GALECTIN THERAPEUTICS INC (GALT) | Grant/Award | 40,000 | n/a |